Improving access to cancer clinical trials and enhancing minority recruitment
Official title: NCI Research Specialist (Clinician Scientist) Award
Funded at Icahn School of Medicine at Mount Sinai · NIH-11057624 · Data updated 2026-11-12
This study is working to make it easier for more people, especially those from diverse backgrounds, to join cancer clinical trials at Mount Sinai, so they can access the latest treatments and help researchers develop new ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 17, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $91,123 |
| NIH project number | 5R50CA276021-03 |
| Project ID | NIH-11057624 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are cancer patients seeking access to clinical trials, particularly those from underrepresented minority groups.
✕Less likely to help
Patients who are not diagnosed with cancer or those who do not meet the eligibility criteria for specific clinical trials may not benefit from this research.
What this research studies
This research focuses on expanding access to cancer clinical trials within the Mount Sinai Health System, aiming to increase the number of NCI-sponsored trials and improve oversight of clinical trial services. The project also supports junior faculty in developing their own investigator-initiated trials and encourages minority recruitment into these trials. By enhancing the infrastructure and support for clinical trials, the research seeks to make cutting-edge cancer treatments more accessible to diverse patient populations.
Why it matters
Potential benefit: If successful, this research could lead to improved access to innovative cancer treatments for a broader range of patients.
How similar studies have gone: Previous research has shown success in increasing clinical trial participation through targeted outreach and support, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Goodman, Karyn a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Goodman, Karyn a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.